These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Atrial fibrillation: a perspective: thinking inside and outside the box. Wyse DG; Gersh BJ Circulation; 2004 Jun; 109(25):3089-95. PubMed ID: 15226225 [No Abstract] [Full Text] [Related]
47. Atrial fibrillation and atrial flutter in athletes. Calvo N; Brugada J; Sitges M; Mont L Br J Sports Med; 2012 Nov; 46 Suppl 1():i37-43. PubMed ID: 23097477 [TBL] [Abstract][Full Text] [Related]
48. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure. Aksnes TA; Flaa A; Strand A; Kjeldsen SE J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167 [TBL] [Abstract][Full Text] [Related]
50. Gastroesophageal reflux disease: another risk factor for atrial fibrillation? Bamimore A; Budzikowski AS Cardiology; 2011; 120(4):185-6. PubMed ID: 22261930 [No Abstract] [Full Text] [Related]
51. Corticosteroids and atrial fibrillation: Risks or benefits? Liu T; Li G Arch Intern Med; 2006 Sep; 166(16):1785-6. PubMed ID: 16983061 [No Abstract] [Full Text] [Related]
52. Long-Term PPI Use: Balancing Potential Harms and Documented Benefits. Laine L; Nagar A Am J Gastroenterol; 2016 Jul; 111(7):913-5. PubMed ID: 27113114 [No Abstract] [Full Text] [Related]
53. [Chemotherapy and NSAIDs in neoplastic disease. Role of anti-secretory preventive therapy]. Annibale B; Panzuto F Recenti Prog Med; 2003 Nov; 94(11):473-7. PubMed ID: 14679914 [TBL] [Abstract][Full Text] [Related]
54. Drug-induced atrial fibrillation: does it matter? Tamargo J; Caballero R; Delpón E Discov Med; 2012 Nov; 14(78):295-9. PubMed ID: 23200060 [TBL] [Abstract][Full Text] [Related]
55. Pathophysiology of atrial fibrillation: current aspects. Lammers WJ; Allessie MA Herz; 1993 Feb; 18(1):1-8. PubMed ID: 7681026 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of use of proton pump inhibitors in Greece. Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607 [TBL] [Abstract][Full Text] [Related]
57. [Proton pump inhibitors, a family of drugs in continuous expansion]. Pellicano R Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085 [No Abstract] [Full Text] [Related]
58. The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation. Li X; Ma C; Dong J; Liu X; Long D; Tian Y; Yu R Med Hypotheses; 2008; 70(2):317-9. PubMed ID: 17689021 [TBL] [Abstract][Full Text] [Related]
59. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422 [TBL] [Abstract][Full Text] [Related]
60. Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Rodrigo R; Cereceda M; Castillo R; Asenjo R; Zamorano J; Araya J; Castillo-Koch R; Espinoza J; Larraín E Pharmacol Ther; 2008 Apr; 118(1):104-27. PubMed ID: 18346791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]